Published in Emerg Infect Dis on November 01, 2010
Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan. PLoS One (2013) 0.94
Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis. Sci Rep (2015) 0.89
Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Natl Acad Sci U S A (2015) 0.88
Appearance of macrolide-resistant Bordetella pertussis strains in China. Antimicrob Agents Chemother (2013) 0.83
Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol (2011) 0.82
Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014). PLoS One (2015) 0.78
Direct molecular typing of Bordetella pertussis from nasopharyngeal specimens in China in 2012-2013. Eur J Clin Microbiol Infect Dis (2016) 0.75
Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun (1998) 3.76
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48
Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis (2000) 3.09
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis (2009) 2.36
Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data. Emerg Infect Dis (2000) 2.29
Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun (1999) 2.09
Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol (2002) 2.02
Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol (2001) 2.02
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines (2009) 1.38
Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur J Clin Microbiol Infect Dis (2000) 1.37
Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect (2005) 1.36
Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol (2004) 1.35
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34
Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol (2004) 1.32
Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol (2005) 1.28
Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol (2005) 1.23
Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines. Vaccine (2001) 1.13
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10
Changing epidemiology and emerging risk groups for pertussis. CMAJ (2006) 1.09
Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05
Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol (2007) 1.04
Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine (2006) 1.04
Essential immunogens in human pertussis: the role of fimbriae. Dev Biol Stand (1985) 1.02
Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan. Vaccine (2008) 1.01
An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands. Vaccine (2009) 0.96
Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997. Microbes Infect (2006) 0.95
Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Expert Rev Vaccines (2005) 0.93
A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect Immun (1998) 0.90
Infantile pertussis rediscovered in China. Emerg Infect Dis (2002) 0.82
Characterization of Bordetella pertussis clinical isolates that do not express the tracheal colonization factor. FEMS Immunol Med Microbiol (2007) 0.77
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med (2005) 6.58
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene (2002) 6.17
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med (2003) 5.96
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci U S A (2007) 4.77
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res (2005) 3.08
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene (2005) 3.05
A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol (2012) 2.81
Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis (2009) 2.36
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults. Clin Infect Dis (2010) 2.20
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol Cancer Ther (2004) 2.10
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. J Natl Cancer Inst (2011) 2.09
Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med (2014) 2.01
An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. ACS Chem Biol (2007) 1.79
Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis (2007) 1.77
An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med (2014) 1.76
Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio (2014) 1.76
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol Cancer Ther (2004) 1.70
A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells. J Biol Chem (2005) 1.70
Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis. J Med Microbiol (2006) 1.69
STAT5 signaling is required for the efficient induction and maintenance of CML in mice. Blood (2006) 1.63
Picornavirus uncoating intermediate captured in atomic detail. Nat Commun (2013) 1.57
Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol (2005) 1.56
Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol (2012) 1.50
Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines (2009) 1.38
Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect (2005) 1.36
Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects. J Immunol (2005) 1.34
Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus. Biochem Biophys Res Commun (2010) 1.30
Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins. Vaccine (2008) 1.29
Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol (2005) 1.28
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines. Vaccine (2011) 1.27
Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strains. BMC Genomics (2008) 1.26
Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. PLoS One (2007) 1.26
Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol (2011) 1.20
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials. Antimicrob Agents Chemother (2006) 1.14
Prediction of breast cancer risk by genetic risk factors, overall and by hormone receptor status. J Med Genet (2012) 1.13
Inflammation is present in early human tendinopathy. Am J Sports Med (2010) 1.12
Prevalence and characterization of Salmonella serovars in retail meats of marketplace in Shaanxi, China. Int J Food Microbiol (2010) 1.09
Wide dissemination of multidrug-resistant Shigella isolates in China. J Antimicrob Chemother (2011) 1.09
A hybrid procedure for MSW generation forecasting at multiple time scales in Xiamen City, China. Waste Manag (2013) 1.07
Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother (2008) 1.07
Progress on the research and development of human enterovirus 71 (EV71) vaccines. Front Med (2012) 1.06
Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009. Virus Genes (2012) 1.06
Prevalence of Salmonella on raw poultry at retail markets in China. J Food Prot (2011) 1.06
Bordetella pertussis, Finland and France. Emerg Infect Dis (2006) 1.05
Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol (2007) 1.04
ND-309, a novel compound, ameliorates cerebral infarction in rats by antioxidant action. Neurosci Lett (2008) 1.04
Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine (2006) 1.04
The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis (2012) 1.03
Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol (2008) 1.02
Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One (2012) 1.02
Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma. Melanoma Res (2009) 1.02
Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab (2013) 1.01
Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol (2011) 1.01
Overexpression of PIM-1 is a potential biomarker in prostate carcinoma. J Surg Oncol (2005) 1.00
A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J Virol (2012) 1.00
Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans. Appl Environ Microbiol (2008) 1.00
The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children. PLoS One (2013) 1.00
Universal anti-neuraminidase antibody inhibiting all influenza A subtypes. Antiviral Res (2013) 0.99
Complete genome sequence of Bordetella pertussis CS, a Chinese pertussis vaccine strain. J Bacteriol (2011) 0.98
A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide. Nat Protoc (2010) 0.98
Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China. Foodborne Pathog Dis (2010) 0.97
Triplex real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis. APMIS (2010) 0.97
Nasopharyngeal bacterial colonization and gene polymorphisms of mannose-binding lectin and toll-like receptors 2 and 4 in infants. PLoS One (2011) 0.96
Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell (2014) 0.95
Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain. Vaccine (2011) 0.95
A phase I clinical-pharmacodynamic study of the farnesyltransferase inhibitor tipifarnib in combination with the proteasome inhibitor bortezomib in advanced acute leukemias. Clin Cancer Res (2011) 0.95
Systematic review and meta-analysis of studies comparing the perimeatal-based flap and tubularized incised-plate techniques for primary hypospadias repair. Pediatr Surg Int (2013) 0.94
PRELI is a mitochondrial regulator of human primary T-helper cell apoptosis, STAT6, and Th2-cell differentiation. Blood (2008) 0.94
Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer (2014) 0.94
A novel synthetic receptor-based immunoassay for influenza vaccine quantification. PLoS One (2013) 0.94
Microarray analysis of response of Salmonella during infection of HLA-B27- transfected human macrophage-like U937 cells. BMC Genomics (2010) 0.93
Acellular pertussis vaccines in China. Vaccine (2012) 0.93
SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One (2011) 0.93
Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J (2010) 0.92
Bioactivity determination of native and variant forms of therapeutic interferons. J Biomed Biotechnol (2011) 0.92
Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences. Vaccine (2010) 0.92
Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China. J Infect (2011) 0.91
Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology (2013) 0.91
Development and calibration of a standard for the protein content of granulocyte colony-stimulating factor products. Biologicals (2012) 0.90
20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain. Phytother Res (2009) 0.90
Enrichment of nucleofected primary human CD4+ T cells: a novel and efficient method for studying gene function and role in human primary T helper cell differentiation. J Immunol Methods (2006) 0.90
Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE. Vaccine (2012) 0.89
MK-2206, an Akt inhibitor, enhances carboplatinum/paclitaxel efficacy in gastric cancer cell lines. Cancer Biol Ther (2013) 0.89
Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis. J Clin Microbiol (2002) 0.89
Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine. Clin Infect Dis (2004) 0.89
PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells. PLoS One (2012) 0.89
A global regulatory science agenda for vaccines. Vaccine (2013) 0.89